$30.16
-0.06-0.20%
At Close: -
$30.19
0.030.10%
After Hours: 3:29 PM EDT
15 minutes delayed
Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics | -$0.67 | — | — | — | $16.51M | — | — | — | 08/01/2024 | Get Alert |
KYMR | Kymera Therapeutics | -$0.70 | -$0.73 | -$0.69 | 5.48% | $9.47M | $13.69M | $10.29M | -24.86% | 05/02/2024 | Get Alert |
KYMR | Kymera Therapeutics | -$0.60 | -$0.40 | -$0.25 | 37.50% | $16.14M | $41.96M | $47.88M | 14.12% | 02/22/2024 | Get Alert |
KYMR | Kymera Therapeutics | -$0.79 | -$0.72 | -$0.90 | -25.00% | $9.55M | $15.97M | $4.73M | -70.39% | 11/02/2023 | Get Alert |
KYMR | Kymera Therapeutics | -$0.78 | -$0.71 | -$0.67 | 5.63% | $11.51M | $14.06M | $16.51M | 17.45% | 08/03/2023 | Get Alert |
KYMR | Kymera Therapeutics | -$0.71 | -$0.68 | -$0.70 | -2.94% | $9.62M | $14.15M | $9.47M | -33.10% | 05/04/2023 | Get Alert |
KYMR | Kymera Therapeutics | -$0.66 | -$0.63 | -$0.60 | 4.76% | $15.28M | $21.58M | $16.14M | -25.21% | 02/23/2023 | Get Alert |
KYMR | Kymera Therapeutics | -$0.56 | -$0.74 | -$0.79 | -6.76% | $20.34M | $15.51M | $9.55M | -38.42% | 11/03/2022 | Get Alert |
KYMR | Kymera Therapeutics | -$0.55 | -$0.72 | -$0.78 | -8.33% | $18.52M | $13.84M | $11.51M | -16.81% | 08/09/2022 | Get Alert |
KYMR | Kymera Therapeutics | -$0.29 | -$0.66 | -$0.71 | -7.58% | $18.70M | $16.23M | $9.62M | -40.71% | 05/03/2022 | Get Alert |
KYMR | Kymera Therapeutics | -$0.29 | -$0.57 | -$0.66 | -15.79% | $12.79M | $21.31M | $15.28M | -28.32% | 02/24/2022 | Get Alert |
KYMR | Kymera Therapeutics | -$0.39 | — | -$0.56 | — | $14.53M | — | $20.34M | — | 11/10/2021 | Get Alert |
KYMR | Kymera Therapeutics | — | -$0.26 | -$0.55 | -111.54% | $3.30M | $18.81M | $18.52M | -1.55% | 08/06/2021 | Get Alert |
KYMR | Kymera Therapeutics | -$10.23 | -$0.19 | -$0.29 | -52.63% | — | $19.80M | $18.70M | -5.55% | 05/06/2021 | Get Alert |
KYMR | Kymera Therapeutics | -$6.06 | — | -$0.29 | — | $1.83M | — | $12.79M | — | 03/11/2021 | Get Alert |
KYMR | Kymera Therapeutics | — | — | -$0.39 | — | $950.00K | — | $14.53M | — | 11/05/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-02 | $-0.69 | $-0.73 | 5.48 % |
Dec 2023 | 2024-02-22 | $-0.25 | $-0.40 | 37.5 % |
Sep 2023 | 2023-11-02 | $-0.90 | $-0.72 | -25.0 % |
Jun 2023 | 2023-08-03 | $-0.67 | $-0.71 | 5.63 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-02 | $10.29M | $13.69M | -24.9 % |
Dec 2023 | 2024-02-22 | $47.88M | $41.96M | 14.1 % |
Sep 2023 | 2023-11-02 | $4.73M | $15.97M | -70.4 % |
Jun 2023 | 2023-08-03 | $16.51M | $14.06M | 17.4 % |
Kymera Therapeutics (KYMR) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
The Actual EPS was $-0.69, which beat the estimate of $-0.73.
The Actual Revenue was $10.3M, which missed the estimate of $13.7M.
Browse earnings estimates, EPS, and revenue on all stocks.